COST EFFECTIVENESS OF PEGFILGRASTIM FOR REDUCING INCIDENCE OF FEBRILE NEUTROPENIA EVENTS AFTER CYTOTOXIC CHEMOTHERAPY FOR SOLID TUMORS IN TURKEY